Position in ANRO
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$287,755
+$286,721 QoQ
Shares Held
10,904
+23604.3% QoQ
Ownership
0.028%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#76
of 114 holders
Holding Since
Mar 2024
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ANRO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026JPMORGAN CHASE & CO holds $12,940,196,194 across 425 Biotechnology names. ANRO ranks #217 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,517,600 | $3,237,487,438 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,774,199 | $2,353,364,036 | |
| 3 | INSM |
INSMED Inc
|
10,428,170 | $1,111,851,478 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,675,517 | $805,410,876 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
3,298,066 | $617,661,794 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
2,652,746 | $294,534,385 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,160,786 | $279,714,596 | |
| 8 | QURE |
uniQure N.V.
|
4,867,755 | $224,208,791 |
All Filings in ANRO
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $287,755 | 10,904 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $1,034 | 46 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $2,598 | 146 | Shares | Defined | 2026-02-11 | |
| 2025-03-31 | $23,649 | 10,949 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $43,318 | 10,241 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $278,163 | 24,315 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $40,397 | 3,779 | Shares | Defined | 2024-12-26 | |
| 2024-03-31 | $383,703 | 24,997 | Shares | Defined | 2024-12-26 | |
| No filing history on record for this holder in this stock. | ||||||